10/08/2026
HER2-positive breast cancer can spread to the brain as a secondary tumor in roughly 30–50% of advanced cases. These metastases are particularly difficult to treat, due to the blood-brain barrier which prevents many cancer drugs from reaching the brain. Scientists are investigating how new cancer drugs are managing to cross the blood-brain barrier to reach target cancer cells.